Skip to main content
main-content

Zeitschrift

Reviews in Endocrine and Metabolic Disorders

Reviews in Endocrine and Metabolic Disorders 3/2021

Ausgabe 3/2021

Advances in Neuroendocrine Neoplasms

Inhaltsverzeichnis ( 12 Artikel )

12.03.2021 | REVIEW PAPER | Ausgabe 3/2021 Open Access

Foreword to the special issue on advances in neuroendocrine neoplasms

Giovanni Vitale, Antongiulio Faggiano

21.10.2020 | Ausgabe 3/2021 Open Access

Epigenetic regulation of somatostatin and somatostatin receptors in neuroendocrine tumors and other types of cancer

M.J. Klomp, S.U. Dalm, M. de Jong, R.A. Feelders, J. Hofland, L.J. Hofland

15.09.2020 | Ausgabe 3/2021 Open Access

From microbiota toward gastro-enteropancreatic neuroendocrine neoplasms: Are we on the highway to hell?

Giovanni Vitale, Alessandra Dicitore, Luigi Barrea, Emilia Sbardella, Paola Razzore, Severo Campione, Antongiulio Faggiano, Annamaria Colao, Manuela Albertelli, Barbara Altieri, Filomena Bottiglieri, Federica De Cicco, Sergio Di Molfetta, Giuseppe Fanciulli, Tiziana Feola, Diego Ferone, Francesco Ferraù, Marco Gallo, Elisa Giannetta, Federica Grillo, Erika Grossrubatscher, Elia Guadagno, Valentina Guarnotta, Andrea M. Isidori, Andrea Lania, Andrea Lenzi, Fabio Lo Calzo, Pasquale Malandrino, Erika Messina, Roberta Modica, Giovanna Muscogiuri, Luca Pes, Genoveffa Pizza, Riccardo Pofi, Giulia Puliani, Carmen Rainone, Laura Rizza, Manila Rubino, Rosa Maria Ruggieri, Franz Sesti, Mary Anna Venneri, Maria Chiara Zatelli, on behalf of NIKE

09.11.2020 | Ausgabe 3/2021 Open Access

Classification of neuroendocrine neoplasms: lights and shadows

Stefano La Rosa, Silvia Uccella

30.03.2021 | Ausgabe 3/2021

Imaging of neuroendocrine tumors: A pictorial review of the clinical value of different imaging modalities

Ali Pirasteh, Petra Lovrec, Lisa Bodei

14.01.2021 | Ausgabe 3/2021

Update in carcinoid heart disease - the heart of the matter

Kira Oleinikov, Amit Korach, David Planer, Dan Gilon, Simona Grozinsky-Glasberg

25.09.2020 | Ausgabe 3/2021 Open Access

PRRT: identikit of the perfect patient

M. Albertelli, A. Dotto, C. Di Dato, P. Malandrino, R. Modica, A. Versari, A. Colao, D. Ferone, A. Faggiano, on behalf of NIKE

03.06.2020 | Ausgabe 3/2021

Theranostics in neuroendocrine tumors: an overview of current approaches and future challenges

Julie Refardt, Johannes Hofland, Antwi Kwadwo, Guillaume P. Nicolas, Christof Rottenburger, Melpomeni Fani, Damian Wild, Emanuel Christ

11.04.2021 | Ausgabe 3/2021 Open Access

Chemotherapy in NEN: still has a role?

Paula Espinosa-Olarte, Anna La Salvia, Maria C. Riesco-Martinez, Beatriz Anton-Pascual, Rocio Garcia-Carbonero

14.04.2021 | Ausgabe 3/2021 Open Access

"Present and future of immunotherapy in Neuroendocrine Tumors"

Manuela Albertelli, Andrea Dotto, Federica Nista, Alessandro Veresani, Luca Patti, Stefano Gay, Stefania Sciallero, Mara Boschetti, Diego Ferone

19.04.2021 | Ausgabe 3/2021

Are recist criteria adequate in assessing the response to therapy in metastatic NEN?

Marie-Pierre Vullierme, Philippe Ruszniewski, Louis de Mestier

06.11.2020 | Ausgabe 3/2021 Open Access

Evaluating cost-effectiveness in the management of neuroendocrine neoplasms

B. E. White, R. Mujica-Mota, T. Snowsill, E. M. Gamper, R. Srirajaskanthan, J. K. Ramage

Aktuelle Ausgaben

Neu im Fachgebiet Innere Medizin

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Innere Medizin und bleiben Sie gut informiert – ganz bequem per eMail.

© Springer Medizin 

Bildnachweise